These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22048111)

  • 1. Recombinant vaccines against leptospirosis.
    Dellagostin OA; Grassmann AA; Hartwig DD; Félix SR; da Silva ÉF; McBride AJ
    Hum Vaccin; 2011 Nov; 7(11):1215-24. PubMed ID: 22048111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Immunoprotection of Leptospira Recombinant Proteins with conventional vaccine in experimental animals.
    Parthiban M; Kumar SS; Balachandran C; Kumanan K; Aarthi KS; Nireesha G
    Indian J Exp Biol; 2015 Dec; 53(12):779-85. PubMed ID: 26742322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.
    Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.
    Dellagostin OA; Grassmann AA; Rizzi C; Schuch RA; Jorge S; Oliveira TL; McBride AJ; Hartwig DD
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.
    Seixas FK; Fernandes CH; Hartwig DD; Conceição FR; Aleixo JA; Dellagostin OA
    Can J Microbiol; 2007 Apr; 53(4):472-9. PubMed ID: 17612601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.
    da Cunha CEP; Bettin EB; Bakry AFAAY; Seixas Neto ACP; Amaral MG; Dellagostin OA
    Vaccine; 2019 Mar; 37(13):1844-1852. PubMed ID: 30826147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.
    Forster KM; Hartwig DD; Oliveira TL; Bacelo KL; Schuch R; Amaral MG; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):989-95. PubMed ID: 26676320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model.
    Lucas DS; Cullen PA; Lo M; Srikram A; Sermswan RW; Adler B
    Vaccine; 2011 Apr; 29(18):3413-8. PubMed ID: 21396409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis.
    Yan W; Faisal SM; McDonough SP; Chang CF; Pan MJ; Akey B; Chang YF
    Vaccine; 2010 Mar; 28(11):2277-83. PubMed ID: 20064477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection.
    Garba B; Bahaman AR; Zakaria Z; Bejo SK; Mutalib AR; Bande F; Suleiman N
    Microb Pathog; 2018 Nov; 124():136-144. PubMed ID: 30138761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection among unrelated leptospira pathogens serovars: an unfinished story.
    Rosario LA; Arencibia DF; Suarez YE; Infante JF; Valdés BY; Batista N
    Adv Clin Exp Med; 2012; 21(5):581-9. PubMed ID: 23356194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis.
    Faisal SM; Yan W; McDonough SP; Mohammed HO; Divers TJ; Chang YF
    Vaccine; 2009 Oct; 27(44):6129-36. PubMed ID: 19715780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation.
    Murray GL; Lo M; Bulach DM; Srikram A; Seemann T; Quinsey NS; Sermswan RW; Allen A; Adler B
    Vaccine; 2013 Jan; 31(3):495-9. PubMed ID: 23176980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the immunogenicity of the leptospiral LipL32, LigAni, and LigBrep recombinant proteins in the sheep model.
    da Rosa MC; Martins G; Rocha BR; Correia L; Ferronato G; Lilenbaum W; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():176-180. PubMed ID: 31300110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.
    Faisal SM; Yan W; McDonough SP; Chang YF
    Vaccine; 2009 Jan; 27(3):378-87. PubMed ID: 19022317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines against leptospirosis: A literature review.
    Silveira MM; Oliveira TL; Schuch RA; McBride AJA; Dellagostin OA; Hartwig DD
    Vaccine; 2017 Oct; 35(42):5559-5567. PubMed ID: 28882437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF; Chen CS; Palaniappan RU; He H; McDonough SP; Barr SC; Yan W; Faisal SM; Pan MJ; Chang CF
    Vaccine; 2007 Nov; 25(48):8190-7. PubMed ID: 17936448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprotective Activity Induced by Leptospiral Outer Membrane Proteins in Hamster Model of Acute Leptospirosis.
    Teixeira AF; Cavenague MF; Kochi LT; Fernandes LG; Souza GO; de Souza Filho AF; Vasconcellos SA; Heinemann MB; Nascimento ALTO
    Front Immunol; 2020; 11():568694. PubMed ID: 33193344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit approach to evaluation of the immune protective potential of leptospiral antigens.
    Félix SR; Hartwig DD; Argondizzo AP; Silva ÉF; Seixas FK; Neto AC; Medeiros MA; Lilenbaum W; Dellagostin OA
    Clin Vaccine Immunol; 2011 Dec; 18(12):2026-30. PubMed ID: 22030369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.